Esmolol Dosing
For acute tachycardia or hypertensive emergencies in adults, administer esmolol as a loading dose of 500-1000 mcg/kg over 1 minute, followed by a continuous infusion starting at 50 mcg/kg/min, with titration in 50 mcg/kg/min increments every 4 minutes as needed, up to a maximum of 200 mcg/kg/min for tachycardia (or 300 mcg/kg/min for hypertension). 1, 2
Clinical Context-Specific Dosing
For Supraventricular Tachycardia or Atrial Fibrillation/Flutter
The FDA-approved regimen uses step-wise dosing 2:
- Loading dose: 500 mcg/kg over 1 minute
- Initial infusion: 50 mcg/kg/min for 4 minutes
- Titration: If inadequate response, repeat the loading bolus (500 mcg/kg over 1 minute) and increase infusion to 100 mcg/kg/min
- Continue titration: Repeat this pattern, increasing by 50 mcg/kg/min increments up to maximum 200 mcg/kg/min
- Maintenance range: 50-200 mcg/kg/min is effective for most patients 3
The 2010 AHA ACLS Guidelines specify the same dosing: 500 mcg/kg (0.5 mg/kg) loading dose over 1 minute, followed by 50 mcg/kg/min (0.05 mg/kg/min) infusion, with repeat boluses and 50 mcg/kg/min incremental increases to a maximum of 300 mcg/kg/min 3. However, doses above 200 mcg/kg/min provide minimal additional heart rate reduction while increasing adverse effects 2.
For Hypertensive Emergencies
The 2017 ACC/AHA Hypertension Guidelines recommend 1, 4, 5, 1:
- Loading dose: 500-1000 mcg/kg/min over 1 minute
- Initial infusion: 50 mcg/kg/min
- Titration: Repeat loading bolus and increase infusion by 50 mcg/kg/min increments as needed
- Maximum: 200 mcg/kg/min (though higher doses of 250-300 mcg/kg/min may be required for hypertension specifically)
Critical caveat: Esmolol is contraindicated in patients with concurrent beta-blocker therapy, bradycardia, or decompensated heart failure 1, 4, 5, 1.
For Perioperative Tachycardia/Hypertension
Two dosing strategies exist based on urgency 2:
Immediate Control:
- Bolus: 1 mg/kg over 30 seconds
- Infusion: 150 mcg/kg/min if necessary
- Adjust as needed to maintain desired heart rate and blood pressure
Gradual Control:
- Bolus: 500 mcg/kg over 1 minute
- Infusion: 50 mcg/kg/min for 4 minutes
- Continue step-wise dosing as outlined for SVT
Research supports that for attenuating intubation response, a loading dose of 500 mcg/kg/min for 4 minutes followed by 200-300 mcg/kg/min infusion is most effective 6. For single-bolus dosing before intubation, 1-2 mg/kg is effective, with 2 mg/kg providing superior rate-pressure product control 7.
For Acute Aortic Dissection
In this life-threatening emergency, esmolol is preferred as first-line therapy 1:
- Goal: Reduce systolic BP to ≤120 mmHg within 20 minutes
- Dosing: Use standard loading and infusion protocol
- Combination: Beta-blockade with esmolol should precede vasodilator administration (nicardipine or nitroprusside) to prevent reflex tachycardia
Pharmacokinetic Considerations
Esmolol has a 2-minute distribution half-life and 9-minute elimination half-life 2, 8. Without a loading dose, steady-state is reached in approximately 30 minutes; with appropriate loading, steady-state is achieved within 5 minutes 2. Substantial recovery from beta-blockade occurs within 10-20 minutes after discontinuation 2.
Important Safety Parameters
- Maintenance duration: Infusions may be continued for up to 48 hours 2
- Monitoring: Watch for hypotension (primary adverse effect) and bradycardia 1, 4, 5
- Contraindications: Avoid in patients with asthma, obstructive airway disease, decompensated heart failure, second- or third-degree heart block, or pre-excited atrial fibrillation 3
- Higher doses: At doses >200 mcg/kg/min, beta-2 receptor blockade may occur, potentially affecting lung function in reactive airway disease 1, 4, 5
Transitioning to Oral Therapy
When converting to alternative antiarrhythmic drugs 2:
- Administer first dose of alternative agent
- 30 minutes later: Reduce esmolol infusion rate by 50%
- After second dose of alternative agent, monitor for 1 hour
- If control is satisfactory, discontinue esmolol infusion
Pediatric Considerations
In neonates and infants, clearance is higher (281 mL/kg/min) and elimination half-life shorter (2.7-4.8 minutes) than in adults 8. Dosing requirements in pediatric post-coarctectomy patients average 700 mcg/kg/min, substantially higher than adult dosing 8, 9.